Covington & Burling (Washington)

Peter Safir

Covington & Burling (Washington)
Lawyer (of Counsel)

Peter Safir has been practicing in the food and drug field for over 25 years and is widely recognized in the pharmaceutical industry as one of the leading food and drug regulatory lawyers in the country. In recent years, Mr. Safir has worked primarily with the research-based pharmaceutical industry concentrating on marketing practices, life cycle management, and issues involving drug quality and manufacturing.

Linked authors

Covington & Burling (Washington)
Covington & Burling (Washington)
Covington & Burling (Washington)
Covington & Burling (Washington)
Covington & Burling (Washington)

Articles

20 Bulletin

Michael Labson, Geoffrey Hobart, Eric Holder, Mark Lynch, Richard Kingham, Peter Safir, Theodore Voorhees Jr, James R. Dean, David W. Addis, Ethan M. Posner The US FTC announces its intention to conduct an extensive study of the economic effects of authorized generic pharmaceuticals

20

On April 4, 2006, the FTC published notice of its intention to conduct an extensive study of the economic effects of authorized generic pharmaceuticals. See 71 Fed. Reg. 16,779 (April 4, 2006). The initial stage of the study would involve detailed information requests, akin to subpoenas, to as (...)

Send a message